Children With and Without Allergic Asthma Experience Less Exacerbation When Dupilumab Is Used.

Published Date: 27 Apr 2023

Children With and Without Allergic Asthma Experience Less Exacerbation After Receiving Dupilumab.

Read Full News

Latest News

Steroids May Ease Cough Severity, Not Rate, in Pneumonitis

Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.

GLP-1s May Curb Asthma Flares in Overweight and Obese Adults

New study suggests joint benefits for respiratory and weight management.

When Patients’ Sleep Disorders Are Linked to Dental Health

With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.

PAP Therapy May Reduce Pulmonary Pressures in Sleep Apnea

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon to Stock Lilly's New Weight-loss Pill At US Kiosks, Offer Same-day Delivery

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Treprostinil Can Slow Lung Decline in Pulmonary Fibrosis

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.

New study suggests joint benefits for respiratory and weight management.

With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

News All Time

Eosinophils, CC16, and the Role of COPD Biomarkers, with Francesca Polverino, MD, PhD Francesca Polverino, MD, PhD, Kevin Kunzmann

Polverino stresses the need for prospective analysis to validate CC16 and mucus plugs as viable biomarkers for COPD status.

Optimizing Lung Volume Reduction Surgery, with Charles Bakhos, MD, MBA, MS Charles Bakhos, MD, MBA, MS, Kevin Kunzmann

Bakhos explains the ideal patient population and strategies inherent to LVRS success.

Managing Perioperative, Postoperative Lung Cancer, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg explains how an emphasis on physical fitness prior to and after surgery can significantly better long-term outcomes.

New CHEST Recommendations Guide Biologic Use for Severe Asthma

New CHEST Recommendations Guide Biologic Use for Severe Asthma

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Recommended News For You

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Recommended Articles For You

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Navigating the Stages of Thyroid Cancer: A Guide for Patients 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

3D virtual staining technology enables non-invasive observation of cancer tissue

2.

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

3.

BMI is linked to heart damage from chemotherapy in breast cancer patients.

4.

New Gene Therapy Nears EU Nod for Bladder Cancer

5.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

1.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

2.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

3.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

4.

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium

5.

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot